On January 6, 2026 Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") reported it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As a global leader in life sciences, Astellas will use this premier platform to highlight its key strategic focuses and the tangible progress achieved to date in support of delivering long-term impact for patients, partners, and shareholders.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the conference, President and CEO Naoki Okamura will present Astellas’ key growth drivers and commitment to disciplined execution. Chief Research & Development Officer Tadaaki Taniguchi will also join the session, and together, they will emphasize how Astellas is advancing transformative scientific breakthroughs for diseases with high unmet medical need and reinforcing its leadership in healthcare innovation and shaping the future of patient care.
Naoki Okamura, President and CEO, Astellas
"Our focus is clear: we are working to turn innovative science into meaningful VALUE for patients and drive sustainable growth. The J.P. Morgan Healthcare Conference provides an exceptional opportunity to engage with the global investment and healthcare community and demonstrate how our strategy and execution position Astellas for long-term success."
Presentation Details
Event: 44th Annual J.P. Morgan Healthcare Conference
Date & Time: January 12, 2026, at 3:00 p.m. PT
Location: Westin St. Francis, San Francisco
The presentation materials and a live webcast link will be available on the Investor Relations page of Astellas.com on the day of the presentation. A link to the on-demand replay will be made available shortly after the presentation.
As a distinguished sponsor of Biotech Showcase held in San Francisco the same week, Astellas is furthering its visibility in the global life sciences community. Chief Strategy Officer Adam Pearson will join a plenary session on partnering trends that are advancing emerging technologies and drug development innovation—underscoring Astellas’ commitment to pioneering science and fostering collaborations to benefit patients worldwide.
(Press release, Astellas Pharma, JAN 6, 2026, View Source [SID1234661772])